Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (12)
  • 2023 (22)
  • 2022 (21)
  • 2021 (53)
  • 2020 (16)

Subject

  • Prescription Drugs (57)
  • Drug Trafficking (48)
  • Pharmaceuticals/Pharmacists/Physicians (45)
  • Diversion Division (42)
  • Synthetic drugs (37)
  • Seizures (Drugs/Property) (30)
  • Task Forces/Task Force Officers (27)
  • Major Law Enforcement Operation (18)
  • Outreach/Drug Prevention (17)
  • Overdose (16)
  • Fake Pills (14)
  • Arrests/Convictions - Major (13)
  • OCDETF/Task Force (13)
  • Guilty Plea (8)
  • Guns/Weapons (8)
  • One Pill Can Kill (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • Press Conferences (6)
  • Fentanyl Awareness (5)
  • Take Back Day (4)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Dark Web- Internet Trafficking (2)
  • Gangs (2)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Narcoterrorism (1)

Drug Name

  • Fentanyl (2491)
  • Methamphetamine (2060)
  • Cocaine (1860)
  • Heroin (1164)
  • Marijuana (Cannabis) (335)
  • Oxycodone (276)
  • Synthetic Opioids (146)
  • Ecstasy/MDMA (49)
  • Hydromorphone (37)
  • Benzodiazepines (23)
  • Morphine (20)
  • Amphetamines (18)
  • Steroids (18)
  • Ketamine (14)
  • Marijuana Concentrates (14)
  • Methadone (13)
  • Xylazine (12)
  • K2/Spice (11)
  • Psilocybin (5)
  • Synthetic Bath Salts or Designer Cathinones (4)
  • GHB (2)
  • Barbiturates (1)
  • Peyote & Mescaline (1)
  • Opioids (119)
  • LSD (10)

Field Division

  • Washington, DC (55)
  • Atlanta (9)
  • Miami (9)
  • San Francisco (8)
  • Seattle (8)
  • New England (7)
  • Dallas (5)
  • Headquarters (5)
  • Houston (5)
  • Chicago (4)
  • St. Louis (4)
  • New York (3)
  • New Jersey (2)
  • Detroit (1)
  • Phoenix (1)
  • Rocky Mountain (1)
  • San Diego (1)
Clear All Results
PRESS RELEASE

Federal Court Issues Temporary Restraining Order Prohibiting Tampa-Area Clinic from Distributing Opioids and Other Prescription Drugs

October 18, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area clinic, its operators and a doctor from administering, dispensing or distributing any controlled substances, including issuing prescriptions for opioids, the Department of Justice announced. In a complaint filed on Oct. 11 and unsealed Oct. 14, the United...
October 18, 2022
PRESS RELEASE

Former Dentist Charged Federally with Illegally Distributing Prescription Opiates

September 13, 2022
SEATTLE – A former dentist who practiced in Renton until his license was indefinitely suspended by the Washington State Dental Commission, was indicted federally for four counts of distributing a controlled substance, announced U.S. Attorney Nick Brown. Luke Edward St. Marie, 34, appeared in federal court today and entered pleas...
September 13, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

July 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
July 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

July 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
July 27, 2022
PRESS RELEASE

Amherst County Veterinarian Sentenced for Opioid Theft

June 22, 2022
LYNCHBURG, Va. – A former veterinarian, who admitted to stealing opioids, was sentenced today to eight months in federal prison. Patrick Gries, 54, of Madison Heights, Virginia, pleaded guilty in January 2022 to one count of adulteration of a drug held for sale after shipment in interstate commerce and one...
June 22, 2022
PRESS RELEASE

Newport News Pharmacy Agrees to Pay Civil Penalty under the Controlled Substances Act

June 21, 2022
NORFOLK, Va. – Hidenwood Pharmacy, Inc., located in Newport News, and its owner, Anne Hutchens, of Seaport, have agreed to pay $125,000 to settle civil penalty claims stemming from alleged record-keeping violations associated with controlled substances. The government alleged that the Hidenwood Pharmacy failed to comply with various recordkeeping requirements...
June 21, 2022
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Pleads Guilty to Conspiracy to Distribute and Dispense Oxycodone

June 16, 2022
Baltimore, Maryland – Norman Rosen, age 84, of Towson, Maryland, pleaded guilty today to conspiracy to distribute and dispense oxycodone in connection with his operation of Rosen-Hoffberg Rehabilitation and Pain Management Associates, P.A., where he was Medical Director and part-owner. The guilty plea was announced by Jarod Forget, Special Agent...
June 16, 2022
PRESS RELEASE

West Barnstable Woman Sentenced for Stealing Opioids from Veterinary Office

June 15, 2022
BOSTON – A West Barnstable woman was sentenced on June 15, 2022 in federal court in Boston in connection with stealing hydrocodone, an opioid and Schedule II controlled substance, from the veterinary office where she worked. Melissa Paradise, 43, was sentenced by U.S. District Court Judge Richard G. Stearns to...
June 15, 2022
PRESS RELEASE

Sovah Health to Pay United States $4.36 Million to Settle Claims of Controlled Substance Act Violations

June 08, 2022
ABINGDON, Va. – Sovah Health has agreed to pay the United States $4.36 million to settle claims that the hospital system violated the Controlled Substances Act (CSA) on numerous occasions between 2017 and 2020. As part of the resolution, Sovah Health further agreed to be subject to a period of...
June 08, 2022
PRESS RELEASE

Consent Decree Approved Between the United States and Baltimore-Based Pharmacy and Pharmacist Alleged to Have Illegally Dispensed Controlled Substances

May 12, 2022
Baltimore, Md. - U.S. District Judge Richard D. Bennett approved the United States’ consent decree with Ketan K. Dankhara, a Baltimore-based pharmacist, and Falls RX, LLC d/b/a Ultra Care Pharmacy Baltimore (“Ultra Care”), resolving the United States’ civil allegations that Dankhara and Ultra Care violated the Controlled Substances Act (“CSA”)...
May 12, 2022
Showing 41 - 50 of 128 results

Pagination

  • First page «
  • Previous page ‹
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Current page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster